• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用E3泛素连接酶重塑肿瘤微环境以进行癌症治疗。

Exploiting E3 ubiquitin ligases to reeducate the tumor microenvironment for cancer therapy.

作者信息

Li Xian-Miao, Zhao Zhen-Yu, Yu Xiao, Xia Qi-Dong, Zhou Peng, Wang Shao-Gang, Wu Huan-Lei, Hu Jia

机构信息

Department of Urology, Institute of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Liberalization Ave, No. 1095, Wuhan, 430030, China.

Department of Geriatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.

出版信息

Exp Hematol Oncol. 2023 Mar 30;12(1):34. doi: 10.1186/s40164-023-00394-2.

DOI:10.1186/s40164-023-00394-2
PMID:36998063
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10061905/
Abstract

Tumor development relies on a complex and aberrant tissue environment in which cancer cells receive the necessary nutrients for growth, survive through immune escape, and acquire mesenchymal properties that mediate invasion and metastasis. Stromal cells and soluble mediators in the tumor microenvironment (TME) exhibit characteristic anti-inflammatory and protumorigenic activities. Ubiquitination, which is an essential and reversible posttranscriptional modification, plays a vital role in modulating the stability, activity and localization of modified proteins through an enzymatic cascade. This review was motivated by accumulating evidence that a series of E3 ligases and deubiquitinases (DUBs) finely target multiple signaling pathways, transcription factors and key enzymes to govern the functions of almost all components of the TME. In this review, we systematically summarize the key substrate proteins involved in the formation of the TME and the E3 ligases and DUBs that recognize these proteins. In addition, several promising techniques for targeted protein degradation by hijacking the intracellular E3 ubiquitin-ligase machinery are introduced.

摘要

肿瘤的发展依赖于复杂且异常的组织环境,在此环境中癌细胞获取生长所需的营养物质,通过免疫逃逸存活,并获得介导侵袭和转移的间充质特性。肿瘤微环境(TME)中的基质细胞和可溶性介质表现出典型的抗炎和促肿瘤活性。泛素化是一种重要的可逆转录后修饰,通过酶促级联反应在调节修饰蛋白的稳定性、活性和定位方面发挥着至关重要的作用。一系列E3连接酶和去泛素化酶(DUB)精细地靶向多种信号通路、转录因子和关键酶,以调控TME几乎所有组分的功能,这一不断积累的证据促使了本综述的撰写。在本综述中,我们系统地总结了参与TME形成的关键底物蛋白以及识别这些蛋白的E3连接酶和DUB。此外,还介绍了几种通过劫持细胞内E3泛素连接酶机制进行靶向蛋白降解的有前景的技术。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f040/10061905/6ac323e35529/40164_2023_394_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f040/10061905/66381ab771f6/40164_2023_394_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f040/10061905/a97be5856f36/40164_2023_394_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f040/10061905/1509e08045a8/40164_2023_394_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f040/10061905/6ac323e35529/40164_2023_394_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f040/10061905/66381ab771f6/40164_2023_394_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f040/10061905/a97be5856f36/40164_2023_394_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f040/10061905/1509e08045a8/40164_2023_394_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f040/10061905/6ac323e35529/40164_2023_394_Fig4_HTML.jpg

相似文献

1
Exploiting E3 ubiquitin ligases to reeducate the tumor microenvironment for cancer therapy.利用E3泛素连接酶重塑肿瘤微环境以进行癌症治疗。
Exp Hematol Oncol. 2023 Mar 30;12(1):34. doi: 10.1186/s40164-023-00394-2.
2
Targeting the Ubiquitin Signaling Cascade in Tumor Microenvironment for Cancer Therapy.靶向肿瘤微环境中的泛素信号级联反应用于癌症治疗。
Int J Mol Sci. 2021 Jan 14;22(2):791. doi: 10.3390/ijms22020791.
3
The intricate interplay between HIFs, ROS, and the ubiquitin system in the tumor hypoxic microenvironment.肿瘤乏氧微环境中 HIFs、ROS 和泛素系统的复杂相互作用。
Pharmacol Ther. 2022 Dec;240:108303. doi: 10.1016/j.pharmthera.2022.108303. Epub 2022 Nov 1.
4
The role of ubiquitination and deubiquitination in tumor invasion and metastasis.泛素化和去泛素化在肿瘤侵袭和转移中的作用。
Int J Biol Sci. 2022 Mar 6;18(6):2292-2303. doi: 10.7150/ijbs.69411. eCollection 2022.
5
E3 Ubiquitin Ligases in Breast Cancer Metastasis: A Systematic Review of Pathogenic Functions and Clinical Implications.E3泛素连接酶在乳腺癌转移中的作用:致病功能及临床意义的系统综述
Front Oncol. 2021 Oct 22;11:752604. doi: 10.3389/fonc.2021.752604. eCollection 2021.
6
The E3 ubiquitin ligases regulate PD-1/PD-L1 protein levels in tumor microenvironment to improve immunotherapy.E3 泛素连接酶调节肿瘤微环境中的 PD-1/PD-L1 蛋白水平,以改善免疫治疗。
Front Immunol. 2023 Jan 17;14:1123244. doi: 10.3389/fimmu.2023.1123244. eCollection 2023.
7
Targeting matrix metalloproteinases by E3 ubiquitin ligases as a way to regulate the tumor microenvironment for cancer therapy.通过 E3 泛素连接酶靶向基质金属蛋白酶以调节肿瘤微环境用于癌症治疗。
Semin Cancer Biol. 2022 Nov;86(Pt 2):259-268. doi: 10.1016/j.semcancer.2022.06.004. Epub 2022 Jun 18.
8
Nonproteolytic K29-Linked Ubiquitination of the PB2 Replication Protein of Influenza A Viruses by Proviral Cullin 4-Based E3 Ligases.非蛋白水解 K29 连接泛素化的流感 A 病毒 PB2 复制蛋白由原病毒 Cullin 4 基 E3 连接酶完成。
mBio. 2020 Apr 7;11(2):e00305-20. doi: 10.1128/mBio.00305-20.
9
The role of ubiquitination in tumorigenesis and targeted drug discovery.泛素化在肿瘤发生和靶向药物发现中的作用。
Signal Transduct Target Ther. 2020 Feb 29;5(1):11. doi: 10.1038/s41392-020-0107-0.
10
The Effect of Dysfunctional Ubiquitin Enzymes in the Pathogenesis of Most Common Diseases.功能失调的泛素酶在大多数常见疾病发病机制中的作用。
Int J Mol Sci. 2020 Sep 1;21(17):6335. doi: 10.3390/ijms21176335.

引用本文的文献

1
A new era in cancer therapy: targeting the Proteasome-Bcl-2 axis.癌症治疗的新时代:靶向蛋白酶体 - Bcl - 2轴。
J Exp Clin Cancer Res. 2025 Aug 21;44(1):246. doi: 10.1186/s13046-025-03505-5.
2
Integrative Multi-Omics Analysis Reveals the Molecular Characteristics, Tumor Microenvironment, and Clinical Significance of Ubiquitination Mechanisms in Lung Adenocarcinoma.整合多组学分析揭示肺腺癌中泛素化机制的分子特征、肿瘤微环境及临床意义。
Int J Mol Sci. 2025 Jul 6;26(13):6501. doi: 10.3390/ijms26136501.
3
SUMO-activating enzyme subunit 1 (SAE1) promotes non-small cell lung cancer metastasis by promoting the epithelial-mesenchymal transition through the SUMOylation of N-cadherin.

本文引用的文献

1
Targeting CSC-related transcription factors by E3 ubiquitin ligases for cancer therapy.通过 E3 泛素连接酶靶向 CSC 相关转录因子进行癌症治疗。
Semin Cancer Biol. 2022 Dec;87:84-97. doi: 10.1016/j.semcancer.2022.11.002. Epub 2022 Nov 9.
2
TRIM family contribute to tumorigenesis, cancer development, and drug resistance.TRIM家族参与肿瘤发生、癌症发展和耐药过程。
Exp Hematol Oncol. 2022 Oct 19;11(1):75. doi: 10.1186/s40164-022-00322-w.
3
The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis.
小泛素样修饰激活酶亚基1(SAE1)通过N-钙黏蛋白的小泛素样修饰促进上皮-间质转化,从而促进非小细胞肺癌转移。
Sci China Life Sci. 2025 Jul 8. doi: 10.1007/s11427-023-2662-y.
4
UBR5 in Tumor Biology: Exploring Mechanisms of Immune Regulation and Possible Therapeutic Implications in MPNST.肿瘤生物学中的UBR5:探索免疫调节机制及在恶性外周神经鞘膜瘤中的潜在治疗意义
Cancers (Basel). 2025 Jan 7;17(2):161. doi: 10.3390/cancers17020161.
5
Crosstalk between O-GlcNAcylation and ubiquitination: a novel strategy for overcoming cancer therapeutic resistance.O-连接的N-乙酰葡糖胺化(O-GlcNAcylation)与泛素化之间的相互作用:一种克服癌症治疗耐药性的新策略。
Exp Hematol Oncol. 2024 Nov 1;13(1):107. doi: 10.1186/s40164-024-00569-5.
6
Emerging druggable targets for immune checkpoint modulation in cancer immunotherapy: the iceberg lies beneath the surface.癌症免疫治疗中免疫检查点调节的新兴可用药靶:冰山在水面之下。
Apoptosis. 2024 Dec;29(11-12):1879-1913. doi: 10.1007/s10495-024-02022-8. Epub 2024 Oct 1.
7
Phase separation-mediated biomolecular condensates and their relationship to tumor.相分离介导的生物分子凝聚物及其与肿瘤的关系。
Cell Commun Signal. 2024 Feb 21;22(1):143. doi: 10.1186/s12964-024-01518-9.
8
Comprehensive Analysis of the SUMO-related Signature: Implication for Diagnosis, Prognosis, and Immune Therapeutic Approaches in Cervical Cancer.SUMO 相关特征的综合分析:对宫颈癌诊断、预后和免疫治疗方法的影响。
Biochem Genet. 2024 Dec;62(6):4654-4678. doi: 10.1007/s10528-024-10728-2. Epub 2024 Feb 13.
9
Crosstalk between colorectal CSCs and immune cells in tumorigenesis, and strategies for targeting colorectal CSCs.结直肠癌干细胞与免疫细胞在肿瘤发生中的相互作用以及靶向结直肠癌干细胞的策略。
Exp Hematol Oncol. 2024 Jan 22;13(1):6. doi: 10.1186/s40164-024-00474-x.
10
E3 ligase TRIM28 promotes anti-PD-1 resistance in non-small cell lung cancer by enhancing the recruitment of myeloid-derived suppressor cells.E3 连接酶 TRIM28 通过增强髓系来源抑制细胞的募集促进非小细胞肺癌对 PD-1 抑制剂的耐药性。
J Exp Clin Cancer Res. 2023 Oct 21;42(1):275. doi: 10.1186/s13046-023-02862-3.
肿瘤进展和转移中 EMT 的分子机制和治疗策略。
J Hematol Oncol. 2022 Sep 8;15(1):129. doi: 10.1186/s13045-022-01347-8.
4
Metabolic profiles of regulatory T cells and their adaptations to the tumor microenvironment: implications for antitumor immunity.调节性 T 细胞的代谢特征及其对肿瘤微环境的适应:对抗肿瘤免疫的影响。
J Hematol Oncol. 2022 Aug 10;15(1):104. doi: 10.1186/s13045-022-01322-3.
5
Targeting micro-environmental pathways by PROTACs as a therapeutic strategy.靶向 PROTACs 的微环境途径作为一种治疗策略。
Semin Cancer Biol. 2022 Nov;86(Pt 2):269-279. doi: 10.1016/j.semcancer.2022.07.001. Epub 2022 Jul 4.
6
Targeting matrix metalloproteinases by E3 ubiquitin ligases as a way to regulate the tumor microenvironment for cancer therapy.通过 E3 泛素连接酶靶向基质金属蛋白酶以调节肿瘤微环境用于癌症治疗。
Semin Cancer Biol. 2022 Nov;86(Pt 2):259-268. doi: 10.1016/j.semcancer.2022.06.004. Epub 2022 Jun 18.
7
Heterogeneity of the tumor immune microenvironment and its clinical relevance.肿瘤免疫微环境的异质性及其临床相关性。
Exp Hematol Oncol. 2022 Apr 23;11(1):24. doi: 10.1186/s40164-022-00277-y.
8
USP25 promotes pathological HIF-1-driven metabolic reprogramming and is a potential therapeutic target in pancreatic cancer.USP25 促进病理性 HIF-1 驱动的代谢重编程,是胰腺癌的一个潜在治疗靶点。
Nat Commun. 2022 Apr 19;13(1):2070. doi: 10.1038/s41467-022-29684-9.
9
A proteolysis-targeting chimera molecule selectively degrades ENL and inhibits malignant gene expression and tumor growth.一种蛋白水解靶向嵌合分子可选择性降解 ENL,抑制恶性基因表达和肿瘤生长。
J Hematol Oncol. 2022 Apr 8;15(1):41. doi: 10.1186/s13045-022-01258-8.
10
USP8 inhibition reshapes an inflamed tumor microenvironment that potentiates the immunotherapy.USP8 抑制重塑了炎症肿瘤微环境,从而增强了免疫治疗效果。
Nat Commun. 2022 Mar 31;13(1):1700. doi: 10.1038/s41467-022-29401-6.